Main Article Content
Aim: Amoxicillin/clavulanate use leads to different adverse effects such as diarrhea, loose stools, skin rashes, nausea,
and urticaria. The aim of the study was to describe the reported adverse events associated with the use of amoxicillin/
clavulanate potassium. Materials and Methods: The study included a descriptive analysis of the reports that were
submitted to the FDA Adverse Event Reporting System (FAERS). Results: Between 1994 and 2022, 2203 reports
about amoxicillin/clavulanate potassium adverse events were submitted to FAERS. The most reported adverse events
were diarrhea (9.03%), pruritus (8.81%), hypersensitivity (7.67%), pyrexia (7.31%), rash (6.95%), dyspnea (5.99%),
vomiting (5.54%), drug ineffective (5.08%), and nausea (4.31%).The present study showed also that amoxicillin/
clavulanate potassium use leads to several adverse events that could be serious events. Conclusion: It is important
to increase the awareness of healthcare providers about the adverse events of broad-spectrum antibiotics such as
amoxicillin/clavulanate potassium. The health-care providers should educate their patients about the adverse events
of using amoxicillin/clavulanate potassium and about how to manage and how to report these events.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.